세계의 모바일 심장 원격 측정 기기 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2033년)

Global Mobile Cardiac Telemetry Device Market size is anticipated to grow from USD 1.87 Billion in 2024 to USD 5.08 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 11.72% during the forecast period of 2026 to 2033.

The Mobile Cardiac Telemetry Device market is poised for remarkable growth as the demand for remote patient monitoring and telehealth solutions continues to rise. With an increasing focus on preventive healthcare and the management of chronic conditions, mobile cardiac telemetry devices are becoming essential tools for healthcare providers. These devices enable continuous monitoring of patients' heart activity, allowing for timely interventions and improved patient outcomes. As technology advances, the integration of mobile telemetry with wearable devices and mobile applications will further enhance the accessibility and effectiveness of cardiac care.

As healthcare systems worldwide strive to reduce costs and improve patient engagement, mobile cardiac telemetry devices offer a viable solution for managing cardiovascular health. By enabling remote monitoring, these devices can reduce the need for hospital visits and allow healthcare providers to track patients' conditions in real-time. This shift not only enhances patient convenience but also empowers healthcare professionals to make informed decisions based on accurate and timely data.

Looking ahead, the Mobile Cardiac Telemetry Device market is expected to witness innovations that enhance device functionality and user experience. Developments in data analytics and artificial intelligence will enable more sophisticated monitoring capabilities, allowing for personalized treatment plans and proactive management of cardiac conditions. As the healthcare landscape continues to evolve, mobile cardiac telemetry devices will play a pivotal role in shaping the future of cardiovascular care, ensuring that patients receive timely and effective interventions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Application

• Lead-based
• Patch-based

By Disease Indication

• Angina Pectoris
• Atherosclerosis
• Heart Failure
• Others

By End-user

• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Home Care Settings
• Others
• COMPANIES PROFILED
• BioTelemetry Inc.
• ScottCare
• Biotricity Inc.
• Welch Allyn
• Applied Cardiac Systems Inc.
• Medicomp Inc.
• Preventice Solutions
• Telerhythmics LLC
• Zoll Medical Corporation
• iRhythm Technologies Inc.
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. MOBILE CARDIAC TELEMETRY DEVICE INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Poerter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Application
  • 3.7.2 Market Attractiveness Analysis By Disease Indication
  • 3.7.3 Market Attractiveness Analysis By End-user
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL MOBILE CARDIAC TELEMETRY DEVICE MARKET ANALYSIS BY APPLICATION

• 5.1. Overview By Application
• 5.2. Historical and Forecast Data Analysis By Application
• 5.3. Lead-based Historic and Forecast Sales By Regions
• 5.4. Patch-based Historic and Forecast Sales By Regions

6. GLOBAL MOBILE CARDIAC TELEMETRY DEVICE MARKET ANALYSIS BY DISEASE INDICATION

• 6.1. Overview By Disease Indication
• 6.2. Historical and Forecast Data Analysis By Disease Indication
• 6.3. Angina Pectoris Historic and Forecast Sales By Regions
• 6.4. Atherosclerosis Historic and Forecast Sales By Regions
• 6.5. Heart Failure Historic and Forecast Sales By Regions
• 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL MOBILE CARDIAC TELEMETRY DEVICE MARKET ANALYSIS BY END-USER

• 7.1. Overview By End-user
• 7.2. Historical and Forecast Data Analysis By End-user
• 7.3. Hospitals Historic and Forecast Sales By Regions
• 7.4. Specialty Clinics Historic and Forecast Sales By Regions
• 7.5. Diagnostic Centers Historic and Forecast Sales By Regions
• 7.6. Home Care Settings Historic and Forecast Sales By Regions
• 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL MOBILE CARDIAC TELEMETRY DEVICE MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE MOBILE CARDIAC TELEMETRY DEVICE COMPANIES

• 9.1. Mobile Cardiac Telemetry Device Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF MOBILE CARDIAC TELEMETRY DEVICE INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. BioTelemetry Inc.
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. ScottCare
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Biotricity Inc.
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Welch Allyn
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Applied Cardiac Systems Inc.
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Medicomp Inc.
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Preventice Solutions
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Telerhythmics LLC
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Zoll Medical Corporation
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. IRhythm Technologies Inc
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies